Flying The Web For News.
  • Epiphany
    Epiphany
  • Career Exam Study
    Career Exam Study
  • 2024 Presidential Election
    2024 Presidential Election
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service


NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of DexCom, Inc.…


Posted: 2024-10-07 19:01:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related News Stories From The Web And More

Related Bing News Search Results

Press Release: DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline - Newscast

DexCom (NASDAQ:DXCM) Stock Rating Upgraded by Robert W. Baird

Fri, 17 Jan 2025 22:50:00 GMT DexCom (NASDAQ:DXCM – Get Free Report) was upgraded by stock analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating in a research report issued on Thursday, MarketBeat reports.

DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback

Fri, 17 Jan 2025 12:43:00 GMT DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to find out why I am neutral on DXCM.

Why DexCom, Inc. (DXCM) Is Skyrocketing

Thu, 16 Jan 2025 15:46:48 GMT We recently compiled a list of the 10 Firms Shine Amid Wall Street’s Lackluster Trading. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other ...

Piper Sandler bullish on DexCom shares citing growth potential and new catalysts

Thu, 16 Jan 2025 09:03:00 GMT Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...

DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 Outlook

Tue, 14 Jan 2025 05:11:00 GMT DexCom, Inc. DXCM reported strong preliminary results for the fourth quarter and full-year 2024. In response, the company’s stock jumped 2.7% on Jan. 13. The company is scheduled to release its ...


Blow Us A Whistle